AI drug discovery
The company also said it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. later this year.
Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solution for months, and decided to forge ahead in spite of the attacks that happened this past…
Biotech, pharmaceutical and life sciences companies all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, according to Deloitte. QuantHealth aims…
It’s encouraging to think that multiple startups will find ways to leverage AI and other fields to accelerate drug discovery and improve patient outcome.
